Year: 2011
Type: article
Abstract: Therapeutic antibodies need international patent protection as their markets expand to include industrialized and emerging countries. Because international intellectual property strategies are frequently complex and costly, applicants require sound information as a basis for decisions regarding the countries in which to pursue patents. While the most important factor is the size of a given market, other factors should also be considered.
Source: mAbs
Author: Ulrich Storz
Institution: Michalski Huettermann and Partner
Language: English
Subfield: Management of Technology and Innovation
Domain: Social Sciences
Open Access status: gold
Estimated APC paid: $3,575
OpenAlex ID: W2094613596